Xintela (XINT) announces that the last patient has been dosed in the company's clinical Phase I/IIa study with XSTEM® in patients with difficult-to-heal venous leg ulcers. XSTEM, which consists of all ...

A comprehensive new market study by Credence Research reveals steady and sustained growth for the Global Silver Wound ...

ConvaTec Group plc ((GB:CTEC)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...

BioStem Technologies (($BSEM)) announced an update on their ongoing clinical study. BioStem Technologies is conducting a clinical study titled A ...

Chronic venous insufficiency damages valves in the leg veins, causing blood to pool. This increases pressure and causes ...

On the United Nations’ International Day of Older Persons, AOP Health draws attention to the often-invisible impact that Chronic Venous Ulcer (CVU) wounds have on older people. CVU are painful, ...

Specialized vein clinics across the U.S. are helping patients restore comfort, improve leg appearance, and enhance overall ...

Meta Analyses & Mega Meta Analysis by Serena Group In addition to clinical trials, BioLab Holdings is supporting ...

The Traditional Wound Care Products Market stood at USD 12.5 billion, driven by continuous use of dressings, bandages, and gauzes across hospitals, clinics, and home care environments. Rising ...

As of Friday, November 07, Organogenesis Holdings Inc.’s ORGO share price has surged by 41.26%, which has investors questioning if this is right time to sell.

From swelling to varicose veins, Charles Leithead, MD, of Ochsner Health, explains why patients should not ignore signs of ...

Medicare payment shift threatens wound graft supply, prompting legislation to preserve access for chronic ulcer patients and address billing issues.